Afleveringen
-
Beverly Tang is the CEO of Starlight Cardiovascular, a company developing a portfolio of devices to address congenital heart defects. In this episode, Beverly discusses the synergies involved in building a multi-product company, creative methods for fundraising, and how to conduct needs finding without formal ties to a health system.
-
Anna Lisa Somera is the CEO of Rhaeos, a company developing the FlowSense device to assess hydrocephalus shunt flow in pediatric and adult patients. In this episode, Anna Lisa discusses how her team chose to use their platform sensor technology to meet the needs of hydrocephalus patients and clinicians. She also addresses the benefits of family involvement in clinical trials, opportunities for non-dilutive funding, and resources outside of Silicon Valley.
-
Zijn er afleveringen die ontbreken?
-
Eric Chehab co-invented a device called the LifeBubble for protecting and securing umbilical cord catheters in neonates. In this episode, Eric discusses how his team developed the product's value proposition and the associated clinical evidence generation strategy while staying financially lean.
Eric's company, Novonate, spun out of the Stanford Biodesign graduate student course and in 2023 was acquired by Laborie, where Eric now works as the Director of Business Development and Upstream Marketing for obstetrics, gynecology & neonatal health.
-
Welcome to Impact1 Voices! At Impact1, our team is working to improve children’s lives from day one through innovative health technology that solves the most impactful problems in pediatric healthcare.
Our team is based at Stanford University’s Mussallem Center for Biodesign, which teaches a repeatable need-based innovation process for developing new technologies to advance health outcomes and health equity.
In this podcast we will be bringing on leaders from around the globe to share insights on their challenges and successes in delivering new solutions to patients.
